Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients
Launched by AIN SHAMS UNIVERSITY · Jan 9, 2023
Trial Information
Current as of August 25, 2025
Completed
Keywords
ClinConnect Summary
The inflammatory component of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) creates a prothrombotic state that necessitates a thrombophylactic strategy for hospitalized patients. Such strategies are difficult to be standardized because certain individuals can have prothrombotic conditions, such as inherited thrombophilia, which predispose them to an additional coagulative risk. Whether outside the hospital or when admitted, patients with inherited thrombophilia need special anticoagulant attention. Identifying such patients, especially in susceptible populations like the Egyp...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult patients diagnosed as COVID -19 by RT-PCR will be included
- Exclusion Criteria:
- • Patients younger than 18 years old Patients on Antithrombotic treatment before COVID-19.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Eman B AbdelFattah, MD
Principal Investigator
Ain Shams University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials